Lung Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 18 years or older
- People who have had their lung cancer confirmed through a tissue or cell sample test showing non-small cell lung cancer (NSCLC)
- People whose cancer is at an advanced or spread stage (Stage III or Stage IV)
- People who are about to begin a new cancer treatment for their advanced or spread disease, whether this is their first treatment or a later one
- People who have already had testing done on their cancer to check for certain genetic markers and protein levels (EGFR, KRAS, ALK, ROS1, and PD-L1)
- People who are willing and able to provide written consent to participate
Who may not be able to join:
- People who have had surgery or radiotherapy for lung cancer within the past 3 months, or chemotherapy within the past 1 month before joining the trial
- People who have a history of blood clots (such as deep vein thrombosis or pulmonary embolism) since their cancer diagnosis, or who have signs of blood clots at the time of joining
- People who regularly take blood-thinning medication for any reason, such as for an irregular heartbeat or previous blood clots
- People whose general health and ability to carry out daily activities is very poor (confirm with trial site what this level means for a specific situation)
- People whose life expectancy is estimated to be less than 3 months
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Melina Verso, Univesity of Perugia
Phone: 0039+0755782326
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Levels of plasma TF, thrombin generation, IL6, vWF, ADAMTS-13 activity, PAI-1and soluble P-selectin
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.